{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:38:43Z","timestamp":1783996723173,"version":"3.55.0"},"reference-count":76,"publisher":"Oxford University Press (OUP)","issue":"Supplement_5","license":[{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In the United States, we are experiencing linked epidemics (a syndemic) of substance use disorders (SUDs) and infections associated with drug use, including unsafe injecting and unsafe sex in exchange for drugs or money. Current drug laws, together with risk-taking behavior among persons with SUDs, contribute to disproportionately high prevalences of these conditions in correctional settings. Detection and treatment of diseases with a high impact on public health are best addressed in the settings where such conditions are most prevalent (ie, jails and prisons for SUDs and chronic infections). The effectiveness, safety, cost of care. and public health impact of these conditions can be improved by means of broader screening and expanded access to specialty consultations through telemedicine\/telehealth, along with broader use of long-acting medications for the treatment of human immunodeficiency virus and SUDs. Expanding telemedicine\/telehealth, first for specialties which do not require advanced technology (eg, infectious diseases, addictions), can eventually lead to further advancements in correctional healthcare.<\/jats:p>","DOI":"10.1093\/infdis\/jiaa001","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T20:09:02Z","timestamp":1578341342000},"page":"S486-S493","source":"Crossref","is-referenced-by-count":13,"title":["Opioid Use and Chronic Infections: The Value of Addressing the Syndemic in Correctional Settings Via Telemedicine Guidance and Broader Use of Long-Acting Medications"],"prefix":"10.1093","volume":"222","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1746-7462","authenticated-orcid":false,"given":"Martin","family":"Krsak","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, University of Colorado School of Medicine, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T","family":"Montague","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Colorado School of Medicine, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Trowbridge","sequence":"additional","affiliation":[{"name":"Spectrum Health Center for Integrative Medicine, Grand Rapids, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C","family":"Johnson","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Colorado School of Medicine, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid A","family":"Binswanger","sequence":"additional","affiliation":[{"name":"Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA"},{"name":"Colorado Permanente Medical Group, Denver, Colorado, USA"},{"name":"Division of General Internal Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,2]]},"reference":[{"key":"2020101904352278600_CIT0001","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2017"},{"key":"2020101904352278600_CIT0002","volume-title":"Drug use, dependence, and abuse among state prisoners and jail inmates, 2007\u20132009","author":"Bronson","year":"2017"},{"key":"2020101904352278600_CIT0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions","volume":"33","author":"Friedmann","year":"2012","journal-title":"Subst Abus"},{"key":"2020101904352278600_CIT0004","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/003335491412900213","article-title":"Hepatitis C seroprevalence among prison inmates since 2001: still high but declining","volume":"129","author":"Varan","year":"2014","journal-title":"Public Health Rep"},{"key":"2020101904352278600_CIT0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M13-1133","article-title":"Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010","volume":"160","author":"Denniston","year":"2014","journal-title":"Ann Intern Med"},{"key":"2020101904352278600_CIT0006","doi-asserted-by":"crossref","first-page":"762","DOI":"10.7326\/0003-4819-144-10-200605160-00010","article-title":"A framework for management of hepatitis C in prisons","volume":"144","author":"Spaulding","year":"2006","journal-title":"Ann Intern Med"},{"key":"2020101904352278600_CIT0007"},{"key":"2020101904352278600_CIT0008"},{"key":"2020101904352278600_CIT0009"},{"key":"2020101904352278600_CIT0010","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/infdis\/jiz133","article-title":"Opioids and infectious diseases: a converging public health crisis","volume":"220","author":"Schwetz","year":"2019","journal-title":"J Infect Dis"},{"key":"2020101904352278600_CIT0011","volume-title":"Integrating responses at the intersection of opioid use disorder and infectious disease epidemics: proceedings of a workshop","author":"National Academies of Sciences, Engineering, and Medicine","year":"2018"},{"key":"2020101904352278600_CIT0012","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1525-1497.2006.00398.x","article-title":"Managing acutely ill substance-abusing patients in an integrated day hospital outpatient program: medical therapies, complications, and overall treatment outcomes","volume":"21","author":"O\u2019Toole","year":"2006","journal-title":"J Gen Intern Med"},{"key":"2020101904352278600_CIT0013","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.15585\/mmwr.mm6743a3","article-title":"Hepatitis A virus outbreaks associated with drug use and Homelessness\u2014California, Kentucky, Michigan, and Utah, 2017","volume":"67","author":"Foster","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020101904352278600_CIT0014","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1377\/hlthaff.2013.1115","article-title":"Survey finds that many prisons and jails have room to improve HIV testing and coordination of postrelease treatment","volume":"33","author":"Solomon","year":"2014","journal-title":"Health Aff"},{"key":"2020101904352278600_CIT0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2105\/AJPH.2014.302071","article-title":"Survey of US correctional institutions for routine HCV testing","volume":"105","author":"Beckwith","year":"2015","journal-title":"Am J Public Health"},{"key":"2020101904352278600_CIT0016","doi-asserted-by":"crossref","first-page":"134","DOI":"10.24875\/AIDSRev.M17000006","article-title":"HIV and HCV in U.S. prisons and jails: the correctional facility as a bellwether over time for the community\u2019s infections","volume":"19","author":"Spaulding","year":"2017","journal-title":"AIDS Rev"},{"key":"2020101904352278600_CIT0017","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1108\/IJPH-07-2016-0028","article-title":"Universal opt-out screening for hepatitis C virus (HCV) within correctional facilities is an effective intervention to improve public health","volume":"13","author":"Morris","year":"2017","journal-title":"Int J Prison Health"},{"key":"2020101904352278600_CIT0018","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(17)31917-7","article-title":"Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial","volume":"390","author":"Margolis","year":"2017","journal-title":"Lancet"},{"key":"2020101904352278600_CIT0019"},{"key":"2020101904352278600_CIT0020"},{"key":"2020101904352278600_CIT0021","author":"Walmsley","edition":"11th"},{"key":"2020101904352278600_CIT0022","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1001\/jama.2018.15782","article-title":"Alternative state-level financing for hepatitis C treatment\u2014the \u201cNetflix model.\u201d","volume":"320","author":"Trusheim","year":"2018","journal-title":"JAMA"},{"key":"2020101904352278600_CIT0023","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1108\/IJPH-07-2016-0028","article-title":"Universal opt-out screening for hepatitis C virus (HCV) within correctional facilities is an effective intervention to improve public health","volume":"13","author":"Morris","year":"2017","journal-title":"Int J Prison Health"},{"key":"2020101904352278600_CIT0024","article-title":"Cost-effectiveness and budgetary impact of HCV testing, treatment and linkage to care in U.S. prisons","author":"Assoumou","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020101904352278600_CIT0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.drugpo.2019.05.010","article-title":"Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV\/hepatitis C co-infection who inject opioids","volume":"72","author":"Barocas","year":"2019","journal-title":"Int J Drug Policy"},{"key":"2020101904352278600_CIT0026","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/COH.0000000000000572","article-title":"Prisons: ignore them at our peril","volume":"14","author":"Kamarulzaman","year":"2019","journal-title":"Curr Opin HIV AIDS"},{"key":"2020101904352278600_CIT0027","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/cid\/civ948","article-title":"Risk of late relapse or reinfection with hepatitis C virus after achieving a sustained virological response: a systematic review and meta-analysis","volume":"62","author":"Simmons","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020101904352278600_CIT0028","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/liv.14011","article-title":"Hepatitis C: is eradication possible?","volume":"39","author":"Lombardi","year":"2019","journal-title":"Liver Int"},{"key":"2020101904352278600_CIT0029","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.amjmed.2015.09.024","article-title":"Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis","volume":"129","author":"Rosenthal","year":"2016","journal-title":"Am J Med"},{"key":"2020101904352278600_CIT0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsat.2016.07.004","article-title":"Post-discharge treatment engagement among patients with an opioid-use disorder","volume":"69","author":"Naeger","year":"2016","journal-title":"J Subst Abuse Treat"},{"key":"2020101904352278600_CIT0031","doi-asserted-by":"crossref","first-page":"s9","DOI":"10.1191\/0269216306pm1124oa","article-title":"Opioids and the immune system","volume":"209","author":"Sacerdote","year":"2006","journal-title":"Palliat Med"},{"key":"2020101904352278600_CIT0032","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/SPC.0b013e3282f5272e","article-title":"Opioid-induced immunosuppression","volume":"2","author":"Sacerdote","year":"2008","journal-title":"Curr Opin Support Palliat Care"},{"key":"2020101904352278600_CIT0033","doi-asserted-by":"crossref","first-page":"11425","DOI":"10.1128\/JVI.78.20.11425-11428.2004","article-title":"Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus","author":"Kummar","year":"2004","journal-title":"J Virol"},{"key":"2020101904352278600_CIT0034","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1001\/jamainternmed.2018.6101","article-title":"Association of prescribed opioids with increased risk of community-acquired pneumonia among patients with and without HIV","volume":"179","author":"Edelman","year":"2019","journal-title":"JAMA Intern Med"},{"key":"2020101904352278600_CIT0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/08897070109511463","article-title":"Active and former injection drug users report of HIV risk behaviors during periods of incarceration","volume":"22","author":"Clarke","year":"2001","journal-title":"Subst Abus"},{"key":"2020101904352278600_CIT0036","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1360-0443.2011.03676.x","article-title":"The effectiveness of opioid maintenance treatment in prison settings: a systematic review","volume":"107","author":"Hedrich","year":"2012","journal-title":"Addiction"},{"key":"2020101904352278600_CIT0037","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction"},{"key":"2020101904352278600_CIT0038","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/add.13779","article-title":"Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England","volume":"112","author":"Marsden","year":"2017","journal-title":"Addiction"},{"key":"2020101904352278600_CIT0039","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMp1900069","article-title":"Opioid use disorder and incarceration\u2014hope for ensuring the continuity of treatment","volume":"380","author":"Binswanger","year":"2019","journal-title":"N Engl J Med"},{"key":"2020101904352278600_CIT0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison\u2013a high risk of death for former inmates","volume":"356","author":"Binswanger","year":"2007","journal-title":"N Engl J Med"},{"key":"2020101904352278600_CIT0041","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1360-0443.2011.03618.x","article-title":"Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration","volume":"107","author":"Larney","year":"2012","journal-title":"Addiction"},{"key":"2020101904352278600_CIT0042","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/10550887.2015.1059217","article-title":"Addiction treatment within U.S. correctional facilities: bridging the gap between current practice and evidence-based care","volume":"34","author":"Wakeman","year":"2015","journal-title":"J Addict Dis"},{"key":"2020101904352278600_CIT0043","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","article-title":"Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system","volume":"75","author":"Green","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"2020101904352278600_CIT0044","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","article-title":"Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial","volume":"386","author":"Rich","year":"2015","journal-title":"Lancet"},{"key":"2020101904352278600_CIT0045","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(10)60742-8","article-title":"Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed","volume":"376","author":"Degenhardt","year":"2010","journal-title":"Lancet"},{"key":"2020101904352278600_CIT0046"},{"key":"2020101904352278600_CIT0047"},{"key":"2020101904352278600_CIT0048"},{"key":"2020101904352278600_CIT0049","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jsat.2012.10.004","article-title":"Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers and attitudes","volume":"44","author":"Matusow","year":"2013","journal-title":"J Subst Abuse Treat"},{"key":"2020101904352278600_CIT0050","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jsat.2019.06.011","article-title":"Court personnel attitudes towards medication-assisted treatment: a state-wide survey","volume":"104","author":"Andraka-Christou","year":"2019","journal-title":"J Subst Abuse Treat"},{"key":"2020101904352278600_CIT0051","year":"2018"},{"key":"2020101904352278600_CIT0052"},{"key":"2020101904352278600_CIT0053","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1086\/508180","article-title":"Opioid dependence: rationale for and efficacy of existing and new treatments","volume":"43","author":"Fiellin","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2020101904352278600_CIT0054","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0376-8716(03)00059-0","article-title":"Clinical efficacy of buprenorphine: comparisons to methadone and placebo","volume":"70","author":"Ling","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"2020101904352278600_CIT0055"},{"key":"2020101904352278600_CIT0056","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0376-8716(03)00057-7","article-title":"Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?","volume":"70","author":"Mendelson","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"2020101904352278600_CIT0057","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: an international review","volume":"4","author":"Yokell","year":"2011","journal-title":"Curr Drug Abuse Rev"},{"key":"2020101904352278600_CIT0058","first-page":"143","article-title":"Management of opioid addiction with buprenorphine: French history and current management","volume":"7","author":"Polom\u00e9ni","year":"2014","journal-title":"Int J Gen Med"},{"key":"2020101904352278600_CIT0059","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/15563650.2016.1244337","article-title":"Clinical effects of unintentional pediatric buprenorphine exposures: experience at a single tertiary care center","volume":"55","author":"Toce","year":"2017","journal-title":"Clin Toxicol"},{"key":"2020101904352278600_CIT0060","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/bja\/57.2.192","article-title":"Clinical actions of fentanyl and buprenorphine: the significance of receptor binding","volume":"57","author":"Boas","year":"1985","journal-title":"Br J Anaesth"},{"key":"2020101904352278600_CIT0061","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drugpo.2017.05.039","article-title":"Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone","volume":"46","author":"Kelty","year":"2017","journal-title":"Int J Drug Policy"},{"key":"2020101904352278600_CIT0062","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11916-016-0549-9","article-title":"New pain management options for the surgical patient on methadone and buprenorphine","volume":"20","author":"Sen","year":"2016","journal-title":"Curr Pain Headache Rep"},{"key":"2020101904352278600_CIT0063","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/ALN.0000000000001633","article-title":"To stop or not, that is the question: acute pain management for the patient on chronic buprenorphine","volume":"126","author":"Anderson","year":"2017","journal-title":"Anesthesiology"},{"key":"2020101904352278600_CIT0064","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0014-5793(02)02746-1","article-title":"Methadone induces CCR5 and promotes AIDS virus infection","volume":"519","author":"Suzuki","year":"2002","journal-title":"FEBS Lett"},{"key":"2020101904352278600_CIT0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11904-019-00436-7","article-title":"Medications for treatment of opioid use disorder among persons living with HIV","volume":"16","author":"Fanucchi","year":"2019","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2020101904352278600_CIT0066"},{"key":"2020101904352278600_CIT0067","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"2020101904352278600_CIT0068","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1176\/appi.ajp.2018.17101112","article-title":"Medications for alcohol and opioid use disorders and risk of suicidal behavior, accidental overdoses, and crime","volume":"175","author":"Molero","year":"2018","journal-title":"Am J Psychiatry"},{"key":"2020101904352278600_CIT0069","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","article-title":"Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population","volume":"85","author":"Morgan","year":"2018","journal-title":"J Subst Abuse Treat"},{"key":"2020101904352278600_CIT0070","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","article-title":"Management of opioid use disorder in the USA: present status and future directions","volume":"393","author":"Blanco","year":"2019","journal-title":"Lancet"},{"key":"2020101904352278600_CIT0071","volume-title":"MacArthur Foundation. State prison healthcare spending.","author":"The Pew Charitable Trusts","year":"2014"},{"key":"2020101904352278600_CIT0072","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/jcm6020020","article-title":"Telehealth: increasing access to high quality care by expanding the role of technology in correctional medicine","volume":"6","author":"Young","year":"2017","journal-title":"J Clin Med"},{"key":"2020101904352278600_CIT0073","article-title":"Access to specialty services: opportunities for expansion of telemedicine to support correctional health care in Colorado","author":"Krsak","year":"2019","journal-title":"Telemedicine J E Health"},{"key":"2020101904352278600_CIT0074","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1089\/1530562042632056","article-title":"Prison telemedicine and telehealth utilization in the United States: state and federal perceptions of benefits and barriers","volume":"10","author":"Larsen","year":"2004","journal-title":"Telemed J E Health"},{"key":"2020101904352278600_CIT0075","author":"Taxman"},{"key":"2020101904352278600_CIT0076","volume-title":"Plotkin MR, Blandford A. Critical connections: getting people leaving prison and jail the mental health care and substance use treatment they need","year":"2017"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/222\/Supplement_5\/S486\/33940687\/jiaa001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/222\/Supplement_5\/S486\/33940687\/jiaa001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T03:22:18Z","timestamp":1665372138000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/222\/Supplement_5\/S486\/5900589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":76,"journal-issue":{"issue":"Supplement_5","published-online":{"date-parts":[[2020,9,2]]},"published-print":{"date-parts":[[2020,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaa001","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10,1]]},"published":{"date-parts":[[2020,9,2]]}}}